- Home
- CUTR vs ACXP Comparison
CUTR vs ACXP Comparison
Compare CUTR & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUTR
- ACXP
- Stock Information
- Founded
- CUTR 1988
- ACXP 2017
- Country
- CUTR United States
- ACXP United States
- Employees
- CUTR N/A
- ACXP N/A
- Industry
- CUTR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- CUTR Health Care
- ACXP Health Care
- Exchange
- CUTR Nasdaq
- ACXP Nasdaq
- Market Cap
- CUTR 9.2M
- ACXP 31.4M
- IPO Year
- CUTR 2004
- ACXP 2021
- Fundamental
- Price
- CUTR $0.40
- ACXP $0.70
- Analyst Decision
- CUTR Hold
- ACXP Strong Buy
- Analyst Count
- CUTR 3
- ACXP 1
- Target Price
- CUTR $3.00
- ACXP $12.00
- AVG Volume (30 Days)
- CUTR 1.6M
- ACXP 390.9K
- Earning Date
- CUTR 11-07-2024
- ACXP 11-12-2024
- Dividend Yield
- CUTR N/A
- ACXP N/A
- EPS Growth
- CUTR N/A
- ACXP N/A
- EPS
- CUTR N/A
- ACXP N/A
- Revenue
- CUTR $155,210,000.00
- ACXP N/A
- Revenue This Year
- CUTR N/A
- ACXP N/A
- Revenue Next Year
- CUTR $4.61
- ACXP N/A
- P/E Ratio
- CUTR N/A
- ACXP N/A
- Revenue Growth
- CUTR N/A
- ACXP N/A
- 52 Week Low
- CUTR $0.28
- ACXP $0.68
- 52 Week High
- CUTR $3.73
- ACXP $5.00
- Technical
- Relative Strength Index (RSI)
- CUTR 48.44
- ACXP 37.94
- Support Level
- CUTR $0.36
- ACXP $0.68
- Resistance Level
- CUTR $0.97
- ACXP $1.25
- Average True Range (ATR)
- CUTR 0.10
- ACXP 0.10
- MACD
- CUTR 0.01
- ACXP 0.01
- Stochastic Oscillator
- CUTR 15.37
- ACXP 3.33
About CUTR Cutera Inc.
Cutera Inc is a medical device company that specializes in designing, developing, manufacturing, marketing, and servicing laser and other energy-based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States segment. Its products enable medical practitioners to perform safe procedures including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.